Der Kardiologe

, Volume 9, Issue 4, pp 277–278 | Cite as

Koronare Therapie der Mehrgefäßerkrankung: Bypass oder PCI?

Journal Club
  • 338 Downloads

Therapy of multivessel coronary disease: bypass or PCI?

Notes

Interessenkonflikt

C. Özcelik gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Bangalore S, Guo Y, Samadashvili Z et al (2015) Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med 372:1213–1222PubMedCrossRefGoogle Scholar
  2. 2.
    Hannan EL, Racz MJ, McCallister BD et al (1999) A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 33:63–72PubMedCrossRefGoogle Scholar
  3. 3.
    Hannan EL, Racz MJ, Walford G et al (2005) Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352:2174–2183PubMedCrossRefGoogle Scholar
  4. 4.
    Hannan EL, Wu C, Walford G et al (2008) Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358:331–341PubMedCrossRefGoogle Scholar
  5. 5.
    Mohr FW, Morice MC, Kappetein AP et al (2013) Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381:629–638PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Klinikum VESTKnappschaftskrankenhaus RecklinghausenRecklinghausenDeutschland

Personalised recommendations